Kymab Succeeds in Revoking Regeneron’s UK VelocImmune® Patents

Kymab Limited, a leading human monoclonal antibody biopharmaceutical company announced today that the English High Court has revoked European Patent EP(UK) 1 360 287 and EP(UK) 2 264 163 owned by Regeneron Pharmaceuticals Inc .